본문 바로가기
  • Home

TLC, HPTLC FINGERPRINTING AND ACUTE ORAL TOXICITY EVALUATION OF HABB-E-AZARAQI: A NUX-VOMICA-BASED TRADITIONAL UNANI FORMULATION

  • CELLMED
  • Abbr : CellMed
  • 2021, 11(3), pp.13-13
  • DOI : 10.5667/CellMed.2021.0013
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : April 16, 2021
  • Accepted : June 30, 2021
  • Published : August 31, 2021

Shabnam Anjum Ara 1 Uzma Viquar 2 Mohammed Zakir 1 Gulam Mohammed Husain 3 Mohammed Abdul Rasheed Naikodi 4 Mohd Urooj 3 Munawwar Husain Kazmi 5

1Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders
2Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (formerly CRIUM)
3Pharmacology and Toxicology Laboratory, National Research Institute of Unani Medicine for Skin Disorders
4Drug Standardization Research Unit, National Research Institute of Unani Medicine for Skin Disorders
5Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD)

Accredited

ABSTRACT

Background and Objective: Nux-vomica based traditional Unani formulation, Habb-e-Azaraqi (HAZ) is an important drug used by Unani physicians since several decades. It possesses Muqawwi-i-A’sab (nervine tonic), Muharrik-i-A’sab (nervine stimulant) properties and is an effective treatment option for diseases like Laqwa (facial palsy), Falij (paralysis), Niqris (gout) and Waja’al-Mafasil (arthritis) etc. The aim of the study is to access and provide information of HAZ for its TLC, HPTLC Fingerprinting defining its clear qualitative perspective and acute oral toxicity evaluation for its safety assessment which was not done earlier, thus contributing in the field of research. Materials and Methods: The chief ingredient, nux-vomica was detoxified as per method mentioned in Unani Pharmacopeia before its use in formulation. TLC and HPTLC was developed under four detection system i.e., UV 366nm, UV 254nm, exposure to iodine vapours and after derivatization with anisaldehyde sulphuric acid. Acute toxicity studies were performed as per OECD Guidelines 425 at a limit dose of 2000 mg/kg. Observations were done for signs of toxicity, body weight, and feed consumption at regular intervals followed by haematological and biochemistry evaluation. Results: The generated data proved the authenticity and established the TLC and HPTLC profile of the formulation. Acute toxicity revealed no significant differences in HAZ-treated animals with respect to body weight gain, feed consumption, haematology, clinical biochemistry evaluation. No significant gross pathological observation was noticed in necropsy. Conclusion: Data of the present study is substantial and scientific proof of HAZ in terms of standardization and toxicity study that can be utilize in future research activities.

Citation status

* References for papers published after 2023 are currently being built.